science1 distinct publisher
Extended Paxlovid courses failed to beat placebo in a long Covid trial
A Mass General Brigham team stretched a five-day antiviral course to as long as 25 days and tested each ingredient on its own. No clinical benefit appeared, which narrows the viral persistence theory without retiring it.
Publishers:statnews.com
Reality
- Evidence62
- Adoption
- Insufficient
- Hype gap+8
- Incentives28
- Confidence